Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEARCA:BADNYSEARCA:DMCYNASDAQ:FIVYNYSEARCA:GERM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBADB.A.D. Etf$11.91$11.91$11.11▼$13.72$9.77M0.961,591 shsN/ADMCYDemocracy International Fund ETF$28.20+0.3%$26.45$23.08▼$28.21$13.82M0.82,250 shs218 shsFIVYYieldMax Dorsey Wright Hybrid 5 Income ETF$39.21+1.3%$36.84$31.41▼$52.51$9.80MN/A11,230 shs9,030 shsGERMAmplify Treatments, Testing and Advancements ETF$19.16$19.16$15.67▼$20.20$10.54M1.081,891 shsN/A12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBADB.A.D. Etf0.00%0.00%0.00%0.00%0.00%DMCYDemocracy International Fund ETF0.00%+1.33%+4.87%+5.46%+7.86%FIVYYieldMax Dorsey Wright Hybrid 5 Income ETF0.00%+3.16%+3.18%+3.10%+3,920,999,900.00%GERMAmplify Treatments, Testing and Advancements ETF0.00%0.00%0.00%0.00%-5.16%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBADB.A.D. EtfN/AN/AN/AN/AN/AN/AN/AN/ADMCYDemocracy International Fund ETFN/AN/AN/AN/AN/AN/AN/AN/AFIVYYieldMax Dorsey Wright Hybrid 5 Income ETFN/AN/AN/AN/AN/AN/AN/AN/AGERMAmplify Treatments, Testing and Advancements ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBADB.A.D. Etf 0.00N/AN/AN/ADMCYDemocracy International Fund ETF 2.81Moderate Buy$28.20N/AFIVYYieldMax Dorsey Wright Hybrid 5 Income ETF 2.68Moderate Buy$39.21N/AGERMAmplify Treatments, Testing and Advancements ETF 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBADB.A.D. EtfN/AN/AN/AN/AN/AN/ADMCYDemocracy International Fund ETFN/AN/AN/AN/AN/AN/AFIVYYieldMax Dorsey Wright Hybrid 5 Income ETFN/AN/AN/AN/AN/AN/AGERMAmplify Treatments, Testing and Advancements ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBADB.A.D. EtfN/AN/A16.67∞N/AN/AN/AN/AN/ADMCYDemocracy International Fund ETFN/AN/A16.65∞N/AN/AN/AN/AN/AFIVYYieldMax Dorsey Wright Hybrid 5 Income ETFN/AN/A24.45∞N/AN/AN/AN/AN/AGERMAmplify Treatments, Testing and Advancements ETFN/AN/A7.10∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBADB.A.D. Etf$0.080.67%N/AN/AN/ADMCYDemocracy International Fund ETF$0.672.38%N/AN/AN/AFIVYYieldMax Dorsey Wright Hybrid 5 Income ETF$5.5014.03%N/AN/AN/AGERMAmplify Treatments, Testing and Advancements ETF$0.140.73%N/AN/AN/ALatest BAD, DMCY, FIVY, and GERM DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/14/2025FIVYYieldMax Dorsey Wright Hybrid 5 Income ETFMonthly$0.972330.33%5/15/20255/15/20255/16/20254/16/2025FIVYYieldMax Dorsey Wright Hybrid 5 Income ETFMonthly$1.028336.11%4/17/20254/17/20254/21/20253/27/2025DMCYDemocracy International Fund ETF$0.09533/28/20253/28/20253/31/20253/19/2025FIVYYieldMax Dorsey Wright Hybrid 5 Income ETF$0.70923/20/20253/20/20253/21/2025(Data available from 1/1/2013 forward)Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBADB.A.D. EtfN/ADMCYDemocracy International Fund ETFN/AFIVYYieldMax Dorsey Wright Hybrid 5 Income ETFN/AGERMAmplify Treatments, Testing and Advancements ETFN/AInsider OwnershipCompanyInsider OwnershipBADB.A.D. EtfN/ADMCYDemocracy International Fund ETFN/AFIVYYieldMax Dorsey Wright Hybrid 5 Income ETFN/AGERMAmplify Treatments, Testing and Advancements ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBADB.A.D. EtfN/A820,000N/ANot OptionableDMCYDemocracy International Fund ETFN/A370,000N/ANot OptionableFIVYYieldMax Dorsey Wright Hybrid 5 Income ETFN/A250,000N/AN/AGERMAmplify Treatments, Testing and Advancements ETFN/A550,000N/ANot OptionableBAD, DMCY, FIVY, and GERM HeadlinesRecent News About These CompaniesAmplia Therapeutics Advances Cancer Drug TrialOctober 30, 2024 | markets.businessinsider.comFDA Provides Positive Feedback on AMPLIFY Trial for Prostate Cancer DiagnosticOctober 14, 2024 | targetedonc.comMpox Variant Sparks Global Concern As Europe, China Ramp Up ScreeningAugust 19, 2024 | benzinga.comAmplify ETFs to Liquidate Three ETFsAugust 15, 2024 | finance.yahoo.comTHNR Amplify Weight Loss Drug & Treatment ETFAugust 1, 2024 | seekingalpha.comFinding Opportunity in Unloved Healthcare ETFsMay 31, 2024 | etftrends.comAdvances in Food and Beverage Testing 2024May 21, 2024 | technologynetworks.comAdvances in Minimally Invasive Treatment of Hand DisordersMay 15, 2024 | medscape.comETFMG Treatments Testing and Advancements ETFFebruary 11, 2024 | thestreet.comETFMG Treatments, Testing and Advancements ETF declares $0.0522 dividendDecember 28, 2023 | msn.comRecent Advances in the Treatment of Systemic Lupus ErythematosusNovember 2, 2023 | medscape.comAdvancements in Sexually Transmitted Disease Diagnostics: A Promising Market with a Projected CAGR of 5.4% to Reach New Heights by 2032September 4, 2023 | medgadget.comGERM ETFMG Treatments, Testing and Advancements ETFAugust 25, 2023 | seekingalpha.comETFMG Treatments, Testing and Advancements ETF declares quarterly distribution of $0.0600June 23, 2023 | msn.comRecent Advances in the Treatment of MelanomaMay 21, 2023 | nejm.orgUse of the Plaque Assay for Testing the Antibiotic Susceptibility of Intracellular BacteriaMay 13, 2023 | medscape.comTesting & TreatmentApril 28, 2023 | webmd.comCutting-edge advances in cancer treatment are underway. Here are 3 that could change lives.April 25, 2023 | usatoday.comAdvances in the Treatment of Vulvovaginal AtrophyApril 22, 2023 | medscape.comJP Morgan Maintains Moderna (MRNA) Neutral RecommendationApril 11, 2023 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Defense Stocks That Will Profit From a Golden DomeBy Chris Markoch | May 30, 2025View 3 Defense Stocks That Will Profit From a Golden DomeBullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsBy Thomas Hughes | May 27, 2025View Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsIntel’s Turnaround May Be the Best Bet No One’s WatchingBy Jeffrey Neal Johnson | May 30, 2025View Intel’s Turnaround May Be the Best Bet No One’s WatchingOllie’s Q1 Earnings: The Good, the Bad, and What’s NextBy Thomas Hughes | June 3, 2025View Ollie’s Q1 Earnings: The Good, the Bad, and What’s NextWalmart Stock Holds as Tariff Risk Spurs SupportBy Gabriel Osorio-Mazilli | May 19, 2025View Walmart Stock Holds as Tariff Risk Spurs SupportBAD, DMCY, FIVY, and GERM Company DescriptionsB.A.D. Etf NYSEARCA:BAD$11.91 0.00 (0.00%) As of 11/29/2023The B.A.D. ETF (BAD) is an exchange-traded fund that is based on the EQM BAD index. The fund tracks a modified equal-weighted index of US-listed companies engaged in betting, alcohol, cannabis, and drugs. BAD was launched on Dec 22, 2021 and is managed by The BAD Investment Company.Democracy International Fund ETF NYSEARCA:DMCY$28.20 +0.08 (+0.28%) As of 06/6/2025 04:10 PM EasternThe Democracy International Fund (DMCY) is an exchange-traded fund that is based on the Democracy Investments International index. The fund tracks an index of global, large- and mid-cap companies outside the US. The index aims to overweight investments in democratic countries while underweighting those in authoritarian countries. DMCY was launched on Mar 31, 2021 and is managed by Democracy.YieldMax Dorsey Wright Hybrid 5 Income ETF NASDAQ:FIVY$39.21 +0.51 (+1.32%) As of 06/6/2025 03:59 PM EasternThe YieldMax Dorsey Wright Hybrid 5 Income ETF (FIVY) is an exchange-traded fund that mostly invests in total market equity. The fund is a passively managed fund-of-funds that tracks an index of five stocks and five affiliated ETFs. The underlying ETFs seek to provide current income and capped gains by employing synthetic covered call strategies, collateralized by cash and US Treasurys. FIVY was launched on Dec 16, 2024 and is issued by YieldMax.Amplify Treatments, Testing and Advancements ETF NYSEARCA:GERM$19.16 0.00 (0.00%) As of 06/6/2025The ETFMG Treatments, Testing and Advancements ETF (GERM) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a tier-weighted, narrow index of US-listed, global biotech companies that are engaged in the testing and treatments of infectious diseases. GERM was launched on Jun 17, 2020 and is managed by ETF Managers Group. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/02 - 06/06 This Banking Giant Just Got a $90 Price Target Upgrade Broadcom Slides on Solid Earnings, AI Outlook Still Strong The Market’s Silent Warning: What Bonds and Gold Reveal Intel's Dual Gamble: AI Innovation Now, Foundry Fortunes Later? MongoDB Affirms Outlook and Accelerates Stock Price Reversal Five Below Pops on Strong Earnings, But Rally May Stall Are NVIDIA's Ethernet Wins Signs of Hope or Horror for Arista? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
